{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:40:59Z","timestamp":1792806059247,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T00:00:00Z","timestamp":1532908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Henan provincial traditional Chinese medicine science research","award":["2017ZY1002"],"award-info":[{"award-number":["2017ZY1002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12951-018-0382-x","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T04:11:37Z","timestamp":1532923897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Combination of NF-kB targeted siRNA and methotrexate in a hybrid nanocarrier towards the effective treatment in rheumatoid arthritis"],"prefix":"10.1186","volume":"16","author":[{"given":"Weifeng","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"key":"382_CR1","doi-asserted-by":"publisher","first-page":"7632","DOI":"10.1039\/c4cc02595d","volume":"50","author":"JM Shin","year":"2014","unstructured":"Shin JM, Kim SH, Thambi T, You DG, Jeon J, Lee JO, Chung BY, Jo DG, Park JH. A hyaluronic acid\u2013methotrexate conjugates for targeted therapy of rheumatoid arthritis. Chem Commun. 2014;50:7632\u20135.","journal-title":"Chem Commun"},{"key":"382_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1021\/mp300539f","volume":"10","author":"V Sethi","year":"2013","unstructured":"Sethi V, Rubinstein I, Kuzmis A, Kastrissios H, Artwohl J, Onyuksel H. Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis. Mol Pharm. 2013;10:728\u201338.","journal-title":"Mol Pharm"},{"key":"382_CR3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s11095-010-0330-4","volume":"28","author":"OMY Koo","year":"2011","unstructured":"Koo OMY, Rubinstein I, \u00d6ny\u00fcksel H. Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis. Pharm Res. 2011;28:776\u201387.","journal-title":"Pharm Res"},{"key":"382_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/art.38878","volume":"67","author":"R Morgan","year":"2015","unstructured":"Morgan R, et al. Expression and function of aminopeptidase N\/CD13 produced by fibroblast-like synoviocytes in rheumatoid arthritis: role of CD13 in chemotaxis of cytokine-activated T cells independent of enzymatic activity. Arthritis Rheum. 2015;67:74\u201385.","journal-title":"Arthritis Rheum"},{"key":"382_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/ard.2003.009944","volume":"63","author":"JM Metselaar","year":"2004","unstructured":"Metselaar JM, Van den Berg WB, Holthuysen AEM, Wauben MHM, Storm G, van Lent P. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann Rheum Dis. 2004;63:348\u201353.","journal-title":"Ann Rheum Dis"},{"key":"382_CR6","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1038\/ncomms5696","volume":"5","author":"L Zhu","year":"2014","unstructured":"Zhu L, Yang T, Li L, Sun L, Hou Y, Hu X, et al. TSC1 controls macrophage polarization to prevent inflammatory disease. Nat Commun. 2014;5:4696.","journal-title":"Nat Commun."},{"key":"382_CR7","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/jam.12273","volume":"115","author":"SE Jang","year":"2013","unstructured":"Jang SE, Hyam SR, Han MJ, Kim SY, Lee BG, Kim DH. Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-kB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages. J Appl Microbiol. 2013;115:888\u201396.","journal-title":"J Appl Microbiol"},{"key":"382_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"PP Tak","year":"2001","unstructured":"Tak PP, Firestein GS. NF-kB: a key role in inflammatory diseases. J Clin Invest. 2001;107:7\u201311.","journal-title":"J Clin Invest."},{"key":"382_CR9","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.joca.2006.04.008","volume":"14","author":"JA Roman-Blas","year":"2006","unstructured":"Roman-Blas JA, Jimenez SA. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthr Cartil. 2006;14:839\u201348.","journal-title":"Osteoarthr Cartil."},{"key":"382_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrd2070","volume":"5","author":"LA O\u2019Neill","year":"2006","unstructured":"O\u2019Neill LA. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat Rev Drug Discov. 2006;5:549\u201363.","journal-title":"Nat Rev Drug Discov."},{"key":"382_CR11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nrd2829","volume":"8","author":"M Gaestel","year":"2009","unstructured":"Gaestel M, Kotlyarov A, Kracht M. Targeting innate immunity protein kinase signalling in inflammation. Nat Rev Drug Discov. 2009;8:480\u201399.","journal-title":"Nat Rev Drug Discov."},{"key":"382_CR12","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1021\/nn103349h","volume":"5","author":"TM Sun","year":"2011","unstructured":"Sun TM, Du JZ, Yao YD, Mao CQ, Dou S, Huang SY, et al. Simultaneous delivery of siRNA and paclitaxel via a \u201ctwo-in-one\u201d micelleplex promotes synergistic tumor suppression. ACS Nano. 2011;5:1483\u201394.","journal-title":"ACS Nano"},{"key":"382_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biomaterials.2017.01.008","volume":"122","author":"Q Wang","year":"2017","unstructured":"Wang Q, Jiang H, Li Y, Chen W, Li H, Peng K, Zhang Z, Sun X. Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials. 2017;122:10\u201322.","journal-title":"Biomaterials"},{"key":"382_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nmat1737","volume":"5","author":"Y Wang","year":"2006","unstructured":"Wang Y, Gao S, Ye WH, Yoon HS, Yang YY. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater. 2006;5:791\u20136.","journal-title":"Nat Mater"},{"key":"382_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73:492\u2013509.","journal-title":"Ann Rheum Dis"},{"key":"382_CR16","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1166\/jbn.2015.2170","volume":"11","author":"E Nogueira","year":"2015","unstructured":"Nogueira E, Lager F, Le Roux D, et al. Enhancing methotrexate tolerance with folate tagged liposomes in arthritic mice. J Biomed Nanotechnol. 2015;11:2243\u201352.","journal-title":"J Biomed Nanotechnol"},{"key":"382_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1517\/17425247.2012.642362","volume":"9","author":"ZA Khan","year":"2012","unstructured":"Khan ZA, Tripathi R, Mishra B. Methotrexate: a detailed review on drug delivery and clinical aspects. Expert Opin Drug Deliv. 2012;9:151\u201369.","journal-title":"Expert Opin Drug Deliv."},{"key":"382_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/mabi.200900291","volume":"10","author":"K Lee","year":"2010","unstructured":"Lee K, Bae KH, Lee Y, Lee SH, Ahn CH, Park TG. Pluronic\/polyethylenimine shell crosslinked nanocapsules with embedded magnetite nanocrystals for magnetically triggered delivery of siRNA. Macromol Biosci. 2010;10:239\u201345.","journal-title":"Macromol Biosci"},{"key":"382_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jconrel.2017.04.043","volume":"258","author":"T Ramasamy","year":"2017","unstructured":"Ramasamy T, Ruttala HB, Gupta B, Poudel BK, Choi HG, Yong CS, Kim JO. Smart chemistry-based nanosized drug delivery systems for systemic applications: a comprehensive review. J Control Release. 2017;258:226\u201353.","journal-title":"J Control Release"},{"key":"382_CR20","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1016\/j.actbio.2014.08.021","volume":"10","author":"T Ramasamy","year":"2014","unstructured":"Ramasamy T, Haidar ZS, Tran TH, et al. Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs. Acta Biomater. 2014;10:5116\u201327.","journal-title":"Acta Biomater"},{"key":"382_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.addr.2009.08.004","volume":"62","author":"S Mao","year":"2010","unstructured":"Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev. 2010;62:12\u201327.","journal-title":"Adv Drug Deliv Rev"},{"key":"382_CR22","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1586\/14737159.5.6.893","volume":"5","author":"A Maitra","year":"2005","unstructured":"Maitra A. Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy. Expert Rev Mol Diagn. 2005;5:893\u2013905.","journal-title":"Expert Rev Mol Diagn."},{"key":"382_CR23","doi-asserted-by":"publisher","first-page":"E128","DOI":"10.1208\/aapsj0902015","volume":"9","author":"VP Torchilin","year":"2007","unstructured":"Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J. 2007;9:E128\u201347.","journal-title":"AAPS J"},{"key":"382_CR24","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2217\/17435889.2.5.711","volume":"2","author":"S Sofou","year":"2007","unstructured":"Sofou S. Surface-active liposomes for targeted cancer therapy. Nanomedicine. 2007;2:711\u201324.","journal-title":"Nanomedicine"},{"key":"382_CR25","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.biomaterials.2004.04.008","volume":"26","author":"EK Park","year":"2005","unstructured":"Park EK, Lee SB, Lee YM. Preparation and characterization of methoxy poly(ethylene glycol)\/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials. 2005;26:1053\u201361.","journal-title":"Biomaterials"},{"issue":"Suppl 1","key":"382_CR26","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1478-6354-13-S1-S5","volume":"13","author":"PP Tak","year":"2011","unstructured":"Tak PP, Kalden JR. Advances in rheumatology: new targeted therapeutics. Arthritis Res Ther. 2011;13(Suppl 1):S5.","journal-title":"Arthritis Res Ther"},{"key":"382_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/mt.2010.27","volume":"18","author":"SS Kim","year":"2010","unstructured":"Kim SS, Ye C, Kumar P, Chiu I, Subramanya S, Wu H, Shankar P, Manjunath N. Targeted delivery of siRNA to macrophages for anti-inflammatory treatment. Mol Ther. 2010;18:993\u20131001.","journal-title":"Mol Ther"},{"key":"382_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.actbio.2016.10.034","volume":"48","author":"T Ramasamy","year":"2017","unstructured":"Ramasamy T, Ruttala HB, Chitrapriya N, et al. Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors. Acta Biomater. 2017;48:131\u201343.","journal-title":"Acta Biomater"},{"key":"382_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41427-018-0034-5","volume":"10","author":"T Ramasamy","year":"2018","unstructured":"Ramasamy T, Ruttala HB, Sundaramoorthy P, et al. Multimodal selenium nanoshell-capped Au@mSiO2 nanoplatform for NIR-responsive chemo-photothermal therapy against metastatic breast cancer. NPG Asia Mater. 2018;10:197\u2013216.","journal-title":"NPG Asia Mater"},{"key":"382_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.carbpol.2013.11.009","volume":"102","author":"T Ramasamy","year":"2014","unstructured":"Ramasamy T, Tran TH, Choi JY, et al. Layer-by-layer coated lipid-polymer hybrid nanoparticles designed for use in anticancer drug delivery. Carbohydr Polym. 2014;102:653\u201361.","journal-title":"Carbohydr Polym"},{"key":"382_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ijpharm.2012.02.028","volume":"427","author":"A Rollett","year":"2012","unstructured":"Rollett A, Reiter T, Nogueira P, Cardinale M, Loureiro A, Gomes A, Cavaco-Paulo A, Moreira A, Carmo AM, Guebitz GM. Folic acid-functionalized human serum albumin nanocapsules for targeted drug delivery to chronically activated macrophages. Int J Pharm. 2012;427:460\u20136.","journal-title":"Int J Pharm"},{"key":"382_CR32","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.2147\/IJN.S140992","volume":"12","author":"J Zhao","year":"2017","unstructured":"Zhao J, Zhao M, Yu C, Zhang X, Liu J, Cheng X, Lee RJ, Sun F, Teng L, Li Y. Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis. Int J Nanomed. 2017;12:6735\u201346.","journal-title":"Int J Nanomed."},{"key":"382_CR33","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s12272-011-1109-9","volume":"34","author":"S Mitragotri","year":"2011","unstructured":"Mitragotri S, Yoo JW. Designing micro- and nano-particles for treating rheumatoid arthritis. Arch Pharmacal Res. 2011;34:1887\u201397.","journal-title":"Arch Pharmacal Res"},{"key":"382_CR34","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","volume":"163","author":"P Charles","year":"1999","unstructured":"Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, Breedveld FC, Smolen JS, Eberl G, deWoody K, Feldmann M, Maini RN. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol. 1999;163:1521\u20138.","journal-title":"J Immunol."},{"key":"382_CR35","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1016\/j.biomaterials.2012.12.051","volume":"34","author":"Y Wan","year":"2013","unstructured":"Wan Y, Han J, Fan G, Zhang Z, Gong T, Sun X. Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity. Biomaterials. 2013;34:3020\u2013303.","journal-title":"Biomaterials"},{"key":"382_CR36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.bbrc.2008.02.034","volume":"369","author":"J Zhu","year":"2008","unstructured":"Zhu J, Yong W, Wu X, Yu Y, Lv J, Liu C, Mao X, Zhu Y, Xu K, Han X, Liu C. Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. Biochem Biophys Res Commun. 2008;369:471\u20137.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-018-0382-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12951-018-0382-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-018-0382-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T01:06:31Z","timestamp":1693789591000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-018-0382-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1186\/s12951-018-0382-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,30]]},"assertion":[{"value":"30 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"58"}}